Treatment of severe acute hepatitis E by ribavirin

Journal of Clinical Virology

Volumn 52, Issue 1, 2011, Pages 60-62

  Gerolami, René ^a,b   Borentain, Patrick ^a,b   Raissouni, Ferdaous ^a   Motte, Anne ^c   Solas, Caroline ^c   Colson, Philippe ^c,d  

^a HÔPITAL DE LA CONCEPTION   (France)

^b University of the Mediterranean Aix Marseille II   (France)

^c TIMONE HOSPITAL   (France)

^d CNRS   (France)

Author keywords

Acute hepatitis E; Autochthonous hepatitis; France; Hepatitis E virus; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN M ANTIBODY; PROTHROMBIN; RIBAVIRIN; VIRUS ANTIBODY; VIRUS RNA;

ACUTE DISEASE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; BLOOD SAMPLING; CASE REPORT; CLINICAL EXAMINATION; DISEASE SEVERITY; GENOTYPE; HEPATIC ENCEPHALOPATHY; HEPATITIS E; HOSPITAL ADMISSION; HUMAN; HYPERBILIRUBINEMIA; IMMUNOCOMPROMISED PATIENT; MALE; MORTALITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WEAKNESS;

ACUTE DISEASE; ANTIVIRAL AGENTS; HEPATITIS ANTIBODIES; HEPATITIS E; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL;

EID: 79961127624     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.06.004     Document Type: Article

References (19)

1. Purcell R.H., Emerson S.U. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008, 48(3):494-503.
2. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8(11):698-709.
3. Wheeler C., Vogt T.M., Armstrong G.L., Vaughan G., Weltman A., Nainan O.V., et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005, 353(9):890-897.
4. Liang T.J. Hepatitis B: the virus and disease. Hepatology 2009, 49(5 Suppl.):S13-S21.
5. Péron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007, 14(5):298-303.
6. Dalton H.R., Stableforth W., Thurairajah P., Hazeldine S., Remnarace R., Usama W., et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:784-790.
7. Dalton H.R., Hazeldine S., Banks M., Ijaz S., Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007, 369(9569):1260.
8. Okamoto H., Takahashi M., Nishizawa T. Features of hepatitis E virus infection in Japan. Intern Med 2003, 42:1065-1071.
9. Ramachandran J., Eapen C.E., Kang G., Abraham P., Hubert D.D., Kurian G., et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004, 19(2):134-138.
10. Navaneethan U., Al Mohajer M., Shata M.T. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008, 28(9):1190-1199.
11. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010, 139(5):1612-1618.
12. Mallet V., Nicand E., Sultanik P., Chakvetadze C., Tessé S., Thervet E., et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010, 153(2):85-89.
13. Colson P., Borentain P., Queyriaux B., Kaba M., Moal V., Gallian P., et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010, 202(6):825-834.
14. Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowski J.T., Robins R.K. Broad-spectrum antiviral activity of virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 1972, 177:705-706.
15. Dixit N.M., Perelson A.S. The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus. Cell Mol Life Sci 2006, 63(7-8):832-842.
16. Pawlotsky J.M. Therapy of hepatitis C: from empiricism to eradication. Hepatology 2006, 43:S207-S220.
17. Inoue J., Nishizawa T., Takahashi M., Aikawa T., Mizuo H., Suzuki K., et al. Analysis of the full-length genome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self-limited hepatitis E. J Med Virol 2006, 78(4):476-484.
18. Colson P., Moal V., Motte A., Borentain P., Henry M., Dhiver C., et al. 39 PCR-documented cases of acute or chronic hepatitis E over a 2-year period in Marseilles, south-eastern France. Hepatology 2008, 48(4):1185A.
19. URL: http://www.promedmail.org/pls/apex/f%3Fp=2400%3A1202%3A3228907707221532%3A%3ANO%3A%3AF2400_P1202_CHECK_DISPLAY,F2400_P1202_PUB_MAIL_ID%3AX,81528.